Letter by Rustemi Regarding Article, "Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])".
作者信息
Rustemi Oriela
机构信息
Department of Neuroscience and Neurosurgery, San Bortolo Hospital, Vicenza, Italy.
出版信息
Stroke. 2017 Apr;48(4):e113. doi: 10.1161/STROKEAHA.116.016512. Epub 2017 Mar 10.
PMID:28283604
Abstract
摘要
Zotero 插件